E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/9/2006 in the Prospect News Biotech Daily and Prospect News Convertibles Daily.

New Issue: Qiagen upsized $270 million 20-year convertibles yield 3.25%, up 33.4%

By Kenneth Lim

Boston, May 9 - Qiagen NV on Tuesday priced an upsized $270 million of 20-year convertible senior notes for a coupon of 3.25% and an initial conversion premium of 33.4%.

The notes were talked at a coupon of 3.125% to 3.625% and an initial conversion premium of 30% to 35%. The size of the deal was initially $220 million. An over-allotment option of $30 million remains.

Goldman Sachs is the bookrunner of the deal, which is distributed outside the United States under Regulation S.

The initial conversion price is $20.

The notes are non-callable for the first seven years, after which they may be called only if Qiagen stock exceeds 130% of the conversion price. There are puts in years seven, 11 and 16.

Qiagen is offering the convertibles through a wholly owned subsidiary but will guarantee the notes. It will seek to list the convertibles in Luxembourg.

Qiagen is a Venlo, Netherlands-based maker of research equipment and instruments for the biotech sector. It said the proceeds will help to "optimize the structure of its balance sheet," which includes repaying existing debt, to finance future acquisitions and for general purposes.

Qiagen stock (Nasdaq: QGEN) closed at $15.28 on Monday before the offering was announced, lower by 0.46% or 7 cents.

Issuer:Qiagen NV
Issue:Convertible senior notes
Bookrunner:Goldman Sachs
Amount:$270 million
Greenshoe:$30 million
Maturity:May 16, 2026
Coupon:3.25%
Price:Par of $100,000
Yield:3.25%
Conversion premium:33.4%
Conversion price:$20
Conversion ratio:5,000
Call protection:Non-callable seven years, thereafter subject to 130% threshold
Puts:Years 7, 11, 16
Price talk:3.125%-3.625%, up 30%-35%
Pricing date:May 9
Settlement date:May 16
Guarantees:Qiagen NV
Distribution:Regulation S
Listing:Luxembourg Stock Exchange
Stock symbol:Nasdaq: QGEN

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.